Outlook Therapeutics, Inc.

DB:41O Stock Report

Market Cap: €109.4m

Outlook Therapeutics, Inc. Company Information

Outlook Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Outlook Therapeutics, Inc.
  • Ticker: 41O
  • Exchange: DB
  • Founded: 2010
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$115.676m
  • Listing Market Cap: US$109.383m
  • Shares Outstanding: 23.66m
  • Website: https://www.outlooktherapeutics.com

Number of Employees

Location

  • Outlook Therapeutics, Inc.
  • Building F
  • Suite 320
  • Iselin
  • New Jersey
  • 08852
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
OTLKNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJun 2016
41ONBST (Boerse-Stuttgart)YesCommon StockDEEURJun 2016
41ODB (Deutsche Boerse AG)YesCommon StockDEEURJun 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/27 08:54
End of Day Share Price 2024/11/27 00:00
Earnings2024/06/30
Annual Earnings2023/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.